High Net Worth Advisory Group LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
High Net Worth Advisory Group LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$78,860
+119.1%
2,000
+100.0%
0.03%
+106.7%
Q3 2022$36,000
+20.0%
1,0000.0%0.02%
+25.0%
Q2 2022$30,000
-3.2%
1,0000.0%0.01%
+9.1%
Q1 2022$31,0000.0%1,0000.0%0.01%0.0%
Q4 2021$31,0001,0000.01%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders